It is not a drug, dietary supplement, or product intended for human or animal consumption.
Approved in 2010, Saxenda (liraglutide) was the first GLP-1 medication approved for weight loss in adults with obesity or overweight with at least one weight-related health issue
J.JonassenT.RittigS.et al
Our manufacturing approach prioritizes: Skin safety and comfort Reliable adhesion Clean, professional product presentation Partner with The Tape Lab If youre researching GLP-1 support patch manufacturers, transdermal wellness patches, or private-label metabolic support products, The Tape Lab provides a fast, scalable solution backed by adhesive expertise
This coordinated engagement across the pancreas, brain, gut, liver, and adipose tissue underlies the mechanistic rationale for dual GLP-1/GIP receptor agonists, and explains why they have been described as super GLP-1RAs, reflecting genuine potentiation of GLP-1 action by GIP receptor agonist co-activation
From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus